Additionally, cytokines, such as interleukin-12 (IL-12) and interleukin-15 (IL-15), are being investigated for their potential as cancer immunotherapies because of their ability to enhance anti-tumor immunity and promote the proliferation and activation of immune effector cells [96]. Here, IL15 is linked to neoplasm.